Novo Nordisk Beating Lilly in Obesity Pill Market: What It Means for Investors
Novo Nordisk is gaining ground on Lilly in the obesity pill market. This article breaks down the drivers, the competi...
Evaluate wide market index fund performance against the SP 500 in retirement planning, emphasizing return consistency and fee impact.
28,313 articlesNovo Nordisk is gaining ground on Lilly in the obesity pill market. This article breaks down the drivers, the competi...
Two bold moves by Eli Lilly are reshaping the billion-dollar obesity drug market. This guide breaks down what happene...
Wednesday brought an outsized move for Sprinklr as earnings beat and optimism around CXM services spurred fresh buyin...
IBM has delivered a multiyear rally, but a 2026 pullback creates a buying opportunity for patient investors. This gui...
An activist investor is pressing for board seats in a high-stakes proxy battle at Lululemon, highlighting questions a...
AGNC Investment's more than 13.5% yield looks tempting, especially in a low-rate world. Yet looming Fed rate changes ...
In a striking contrast, Nancy Pelosi buys bullish calls on Amazon as Berkshire Hathaway scales back its Amazon exposu...
A high-profile crypto photo shoot has reignited debates about credibility, PR tactics, and the road ahead for a marke...
Ripple and North Island Ventures have led a $6 million funding round for Squid, the cross-chain platform, as the comp...
When a company's chief financial officer sells a sizable stake, investors want to know what it means. This deep dive ...
The 13F filings show billionaire david tepper goes big on Alphabet, Micron, and Meta, while dialing back on Alibaba a...
A majority of Americans fear AI-driven job losses will push the cost and effort of buying a home out of reach, accord...